A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey-Reference-Cited by-同舟云学术

A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey

Published:2015-03-04 Issue:1 Volume:16 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

MacLennan Steven,Bekema Hendrika J,Williamson Paula R,Campbell Marion K,Stewart Fiona,MacLennan Sara J,N’Dow James MO,Lam Thomas BL

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-015-0598-0.pdf

Reference52 articles.

1. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization International Agency for Research on Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 16 Feb 2015.

2. United States Cancer Statistics (USCS): 1999–2010 cancer incidence and mortality data. Centers for Disease Control and Prevention, Division of Cancer Prevention and Control. 2011. http://apps.nccd.cdc.gov/uscs/. Accessed 16 Feb 2015.

3. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, et al. The risk of prostate cancer amongst black men in the United Kingdom: The PROCESS cohort study. Eur Urol. 2008;53:99–105.

4. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.

5. Prostate cancer incidence statistics. Cancer Research UK. 2013. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/incidence/. Accessed 16 Feb 2015.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis;Orphanet Journal of Rare Diseases;2023-11-23

2. Prioritization of Research Engaged with Rare Disease Stakeholders: A Systematic Review and Thematic Analysis;2023-06-01

3. A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology;Cancers;2022-10-19

4. Reply to Ruobing Lei, Yuehuan Li, and Yaolong Chen’s Letter to the Editor re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503–14. Improving the Methodological Quality of Prostate Cancer Core Outcome Sets in Future Updates;European Urology;2022-09

5. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium;European Urology;2022-05